Publications

Sort by: Date | Author | Title

Høgdall, E. V. S., Ryan, A., Kjaer, S. K., Blaakaer, J., Christensen, L., Bock, J. E., Glud, E., Jacobs, I. J. & Høgdall, C. K. (2004). Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study. Cancer, 100(11), 2387-95. https://doi.org/10.1002/cncr.20213
Emonard, H., Bellon, G., Troeberg, L., Berton, A., Robinet, A., Henriet, P., Marbaix, E., Kirkegaard, K., Patthy, L., Eeckhout, Y., Nagase, H., Hornebeck, W. & Courtoy, P. J. (2004). Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism. Journal of Biological Chemistry, 279(52), 54944-51. https://doi.org/10.1074/jbc.M406792200
Knudsen, U. B., Tabor, A., Mosgaard, B. J., Andersen, E. S., Kjer, J. J., Hahn-Pedersen, S., Toftager-Larsen, K. & Mogensen, O. (2004). Management of ovarian cysts. Acta Obstetricia et Gynecologica Scandinavica, 83(11), 1012-21. https://doi.org/10.1111/j.0001-6349.2004.00607.x
Rokkones E, Löfgren M, Härkki P, Arason G. (2004). Nordic gynecologists' opinion on quality assessment registers. Acta Obstetricia et Gynecologica Scandinavica, 83(6).
Schiøtt, K. M. & Uldbjerg, N. (2004). Obstetrisk ultralydskanning: hvornår, hvordan og hvorfor? Månedskrift for Praktisk Lægegerning, 82(10), 1159-1169.
Nilas, L. & Knudsen, U. B. (2004). Operativ behandling af blødningsforstyrrelser. Ugeskrift for Læger, 166(8), 708-9.
Jensen, D. M., Damm, P., Moelsted-Pedersen, L., Ovesen, P., Westergaard, J. G., Moeller, M. & Beck-Nielsen, H. (2004). Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care, 27(12), 2819-23.
Knudsen, U. B., Glavind-Kristensen, M., Jørgensen, H. S. & Ottesen, B. S. (2004). Referenceprogram om hysterektomi i Danmark. Ugeskrift for Læger, 166(13), 1213-5.
Foldspang, A., Hvidman, L., Mommsen, S. & Nielsen, J. B. (2004). Risk of postpartum urinary incontinence associated with pregnancy and mode of delivery. Acta Obstetricia et Gynecologica Scandinavica, 83(10), 923-927.
Linnet, K. M., Wisborg, K., Obel, C., Secher, N. J., Thomsen, P. H., Agerbo, E. & Henriksen, T. B. (2004). Smoking during pregnancy and the risk of hyperkinetic disorder in the offsprin. Audio-Digest Pediatrics, 1391-1002.
Begum, E. V., Hogdall, C. K., Kjaer, S. K., Christensen, L., Blaakær, J., Bock, J. E., Glud, E., Hoyer-Hansen, G., Ring-Larsen, H. & Hogdall, E. V. (2004). The prognostic value of plasma solube urokinase plasminogen activator receptor suPAR levels in stage III ovarian cancer patients. Anticancer Research, May-June(24), 1981-1985.
Obel, C., Heiervang, E., Rodriguez, A., Heyerdahl, S., Smedje, H., Sourander, A., Guethmundsson, O. O., Clench-Aas, J., Christensen, E., Heian, F., Mathiesen, K. S., Magnússon, P., Njarethvík, U., Koskelainen, M., Rønning, J. A., Stormark, K. M. & Olsen, J. (2004). The Strengths and Difficulties Questionnaire in the Nordic countries. European Child & Adolescent Psychiatry, 13(Suppl 2), II32-9. https://doi.org/10.1007/s00787-004-2006-2
nullNielsenC., B., nullS., K., nullR., Ø., nullA., F., nullJ., N., Forman, A. & nullL, W. (2004). Transforming growth factor betal-induced glomerulopathy is prevented by 17betaestradiol supplementation. Virchows Arch, Jun(144(6)), 561-566.
Laigaard, J., Sørensen, T., nullC., F., Pedersen, B. N., Christiansen, M., Schiøtt, K. M., Uldbjerg, N., Albrechtsen, R., Clausen, H. V., Ottesen, B. & Wewer, U. M. (2003). ADAM12 and its application in first-trimester maternal serum screening for Down's syndrome: Development and characterization of an ELISA specific for ADAM12. Prenatal Diagnosis, 23(13), 1086-1091.
Laigaard, J., Sørensen, T., Fröhlich, C., Pedersen, B. N., Christiansen, M., Schiøtt, K. M., Uldbjerg, N., Albrechtsen, R., Clausen, H. V., Ottesen, B. & Wewer, U. M. (2003). ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenatal Diagnosis, 23(13), 1086-91. https://doi.org/10.1002/pd.762
Lauenborg, J., Mathiesen, E., Ovesen, P. G., Westergaard, J. G., Ekbom, P., Mølsted-Pedersen, L. & Damm, P. (2003). Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care, 26(5), 1385-9.
Tsoi, L., Sindos, M., Pisal, N., Michala, S., Jacobs, A., Wisborg, K., Hedegaard, M., Henriksen, T. B., Kesmodel, U. & Bech, B. H. (2003). Consumption of coffee during pregnancy. British Medical Journal, 326(7401), 1268-1269.
Høgdall, E. V. S., Christensen, L., Kjaer, S. K., Blaakær, J., Bock, J. E., Glud, E., Nørgaard-Pedersen, B. & Høgdall, C. K. (2003). Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study. Cancer, 98(1), 66-73. https://doi.org/10.1002/cncr.11476
Høgdall, E. V. S., Johansen, J. S., Kjaer, S. K., Price, P. A., Christensen, L., Blaakær, J., Bock, J. E., Glud, E. & Høgdall, C. K. (2003). High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. Oncology Reports, 10(5), 1535-8.
Løkkegaard, E. & Secher, N. J. (2003). Ingen beskyttende effekt af postmenopausal hormonbehandling på demens. Ugeskrift for Læger, 4125-4126.
Wisborg, K., Kesmodel, U., Bech, B. H., Hedegaard, M. & Henriksen, T. B. (2003). Kaffe og dødfødsel. Tidsskrift for Den norske legeforening, 123(13-14).
Humaidan, P. S., Agerholm, I., Ingerslev, H. J., Pedersen, C., Gerstoft, J. & Andersen, A. N. (2003). Kunstig befrugtning af hiv-positive--en risikoreducerende behandling. Ugeskrift for Læger, 165(48), 4632-5.
Sørensen, K. E., Uldbjerg, N., Levitt, G., Dorup, I., Bull, C. & Sullivan, I. E. (2003). Late anthracycline cardiotoxicity after childhood cancer: A prospective longitudinal study. Cancer, 97, 1991-1998.